GLMD (Galmed Pharmaceuticals) Kacepetan wutah bathi saben saham ing taun lumaku

Simbol resmi perusahaan galmedpharma.com (GLMD)

The financial stability of Galmed Pharmaceuticals (GLMD) relies on the non-cyclical nature of biotech development, where cash is more critical than GDP. The YoY EPS dynamics on the GURU.Markets chart confirm this, while the 40.00 level captures the current state. The company is actively developing the drug Aramchol; however, geopolitical disruptions and sanctions are significantly hindering global certification and the conduct of international clinical trials.

GLMD (Galmed Pharmaceuticals Ltd) riwayat Wutah bathi ing taun lumaku saka 04.07.2022 nganti 10.09.2026

Rincian analitis lan laporan data perusahaan Galmed Pharmaceuticals Ltd (GLMD)

Analisis dhasar perusahaan:GLMD, Galmed Pharmaceuticals
Produk asil prodhuksi Galmed Pharmaceuticals Ltd.

This metric is calculated as the percentage deviation of current earnings per share from the value of the same period last year, measuring the efficiency rates of net income generation. This metric allows for an assessment of the issuer's fundamental stability through the dynamics of profit capitalization. For Galmed Pharmaceuticals (GLMD), during a period of organic asset development and pipeline revision, the current level of EPS YoY change reflects the actual productivity of targeted collaborations.